Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Yamada

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Pharmaceutics|April 6, 2010
Transgene expression efficiency from plasmid DNA delivered as a complex with histone H3Hiroyuki Kamiya, Hitomi Goto, Genki Kanda, et al.
Scientific Reports|May 7, 2020
Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 geneYuma Yamada, Kana Somiya, Akihiko Miyauchi, et al.
Journal of Bioscience and Bioengineering|June 6, 2013
Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptideEriko Kawamura, Yuma Yamada, Yukari Yasuzaki, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of multifunctional envelope type artificial viral-like gene delivery system]Hideyoshi Harashima, Kentaro Kogure, Yuma Yamada, et al.
Advances in Genetics|November 21, 2014
Multifunctional enveloped nanodevices (MENDs)Yusuke Sato, Takashi Nakamura, Yuma Yamada, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2018
Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial diseaseTakuya Ishikawa, Kana Somiya, Reina Munechika, et al.
Biological & Pharmaceutical Bulletin|November 3, 2025
Mitochondrial Activation and Therapeutics: Innovations in Cell- and Organelle-Specific MedicineItsumi Sato, Masahiro Shiraishi, Kaede Norota, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Biomaterials|July 16, 2019
Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistributionTakashi Nakamura, Yuma Yamada, Yusuke Sato, et al.
Advanced Drug Delivery Reviews|September 28, 2020
Power of mitochondrial drug delivery systems to produce innovative nanomedicinesYuma Yamada, Satrialdi, Mitsue Hibino, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Pharmaceutics|April 6, 2010
Transgene expression efficiency from plasmid DNA delivered as a complex with histone H3Hiroyuki Kamiya, Hitomi Goto, Genki Kanda, et al.
Scientific Reports|May 7, 2020
Validation of a mitochondrial RNA therapeutic strategy using fibroblasts from a Leigh syndrome patient with a mutation in the mitochondrial ND3 geneYuma Yamada, Kana Somiya, Akihiko Miyauchi, et al.
Journal of Bioscience and Bioengineering|June 6, 2013
Intracellular observation of nanocarriers modified with a mitochondrial targeting signal peptideEriko Kawamura, Yuma Yamada, Yukari Yasuzaki, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 6, 2007
[Development of multifunctional envelope type artificial viral-like gene delivery system]Hideyoshi Harashima, Kentaro Kogure, Yuma Yamada, et al.
Advances in Genetics|November 21, 2014
Multifunctional enveloped nanodevices (MENDs)Yusuke Sato, Takashi Nakamura, Yuma Yamada, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 7, 2018
Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial diseaseTakuya Ishikawa, Kana Somiya, Reina Munechika, et al.
Biological & Pharmaceutical Bulletin|November 3, 2025
Mitochondrial Activation and Therapeutics: Innovations in Cell- and Organelle-Specific MedicineItsumi Sato, Masahiro Shiraishi, Kaede Norota, et al.
Biological & Pharmaceutical Bulletin|August 5, 2014
RNA aptamers for targeting mitochondria using a mitochondria-based SELEX methodYuri Tawaraya, Mamoru Hyodo, Mst Naznin Ara, et al.
Biomaterials|July 16, 2019
Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistributionTakashi Nakamura, Yuma Yamada, Yusuke Sato, et al.
Advanced Drug Delivery Reviews|September 28, 2020
Power of mitochondrial drug delivery systems to produce innovative nanomedicinesYuma Yamada, Satrialdi, Mitsue Hibino, et al.
Pageof 12